250 ML vancomycin 5 MG/ML Injection — RxCUI 2387078
RxNorm drug concept · Semantic clinical drug
RxCUI 2387078
Semantic clinical drug · SCD
● Current RxNorm concept 22 FDA products
28 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2387078
Official name250 ML vancomycin 5 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asvancomycin 1.25 GM per 250 ML Injection; vancomycin 1.25 GM in 250 ML Injection; vancomycin 1250 MG per 250 ML Injection
FDA products mapped22
Package NDCs mapped28
Reported Medicaid activity (SDUD)22,232 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Vancomycin Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- When vancomycin is given by IV, it gets directly into your bloodstream and reaches infections in your blood, heart, bones, lungs, or skin. When it's swallowed, it mostly stays in y...
- Why am I getting vancomycin by IV instead of taking a pill?
- The most common thing people notice is flushing, redness, or itching on the face, neck, and upper chest — especially if the infusion runs too fast. This is sometimes called 'Red Ma...
- What should I watch for during my vancomycin infusion?
🕸️ Concept Web — How 250 ML vancomycin 5 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
250 ML vancomycin 5 MG/ML Injection
RxCUI 2387078 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Vancomycin
11124IN
-
Vancomycin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Tyzavan
2725131BN
-
Tyzavan
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Vancomycin Injection
1807507SCDF -
Vancomycin Injectable Product
1160499SCDG -
Vancomycin Injection [Tyzavan]
2725134SBDF -
Tyzavan Injectable Product
2725133SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Vancomycin Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Vancomycin 5 MG/ML
330528SCDC -
250 ML vancomycin 5 MG/ML Injection [Tyzavan]
2727215SBD -
Vancomycin 5 MG/ML [Tyzavan]
2725132SBDC
-
Vancomycin 5 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Vancomycin 5 MG/ML
SCDC · 330528 -
Vancomycin Injection
SCDF · 1807507 -
Vancomycin Injectable Product
SCDG · 1160499
Brand-Name Concepts
-
250 ML vancomycin 5 MG/ML Injection [Tyzavan]
SBD · 2727215 -
Vancomycin 5 MG/ML [Tyzavan]
SBDC · 2725132 -
Vancomycin Injection [Tyzavan]
SBDF · 2725134 -
Tyzavan Injectable Product
SBDG · 2725133 -
Tyzavan
BN · 2725131
📦 FDA Products & Package NDCs
22 products · 28 package NDCs
28 package NDCs map to RxCUI 2387078 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9466-06 | 6 BAG in 1 CARTON (0143-9466-06) / 250 mL in 1 BAG (0143-94... | TYZAVAN | Hikma Pharmaceuticals USA Inc. | 2025-10-17 |
| 00143-9467-06 | 6 BAG in 1 CARTON (0143-9467-06) / 350 mL in 1 BAG (0143-94... | TYZAVAN | Hikma Pharmaceuticals USA Inc. | 2025-10-17 |
| 00143-9468-06 | 6 BAG in 1 CARTON (0143-9468-06) / 150 mL in 1 BAG (0143-94... | TYZAVAN | Hikma Pharmaceuticals USA Inc. | 2025-10-17 |
| 00143-9468-12 | 12 BAG in 1 CARTON (0143-9468-12) / 150 mL in 1 BAG (0143-9... | TYZAVAN | Hikma Pharmaceuticals USA Inc. | 2025-10-17 |
| 00143-9469-06 | 6 BAG in 1 CARTON (0143-9469-06) / 300 mL in 1 BAG (0143-94... | TYZAVAN | Hikma Pharmaceuticals USA Inc. | 2025-10-17 |
| 00143-9470-06 | 6 BAG in 1 CARTON (0143-9470-06) / 400 mL in 1 BAG (0143-94... | TYZAVAN | Hikma Pharmaceuticals USA Inc. | 2025-10-17 |
| 00143-9471-06 | 6 BAG in 1 CARTON (0143-9471-06) / 100 mL in 1 BAG (0143-94... | TYZAVAN | Hikma Pharmaceuticals USA Inc. | 2025-10-17 |
| 00143-9471-12 | 12 BAG in 1 CARTON (0143-9471-12) / 100 mL in 1 BAG (0143-9... | TYZAVAN | Hikma Pharmaceuticals USA Inc. | 2025-10-17 |
| 00143-9472-06 | 6 BAG in 1 CARTON (0143-9472-06) / 200 mL in 1 BAG (0143-94... | TYZAVAN | Hikma Pharmaceuticals USA Inc. | 2025-10-17 |
| 00143-9472-12 | 12 BAG in 1 CARTON (0143-9472-12) / 200 mL in 1 BAG (0143-9... | TYZAVAN | Hikma Pharmaceuticals USA Inc. | 2025-10-17 |
| 00338-0122-04 | 250 mL in 1 BAG (0338-0122-04) | VANCOMYCIN HYDROCHLORIDE | Baxter Healthcare Corporation | 2024-01-25 |
| 00338-0124-04 | 300 mL in 1 BAG (0338-0124-04) | VANCOMYCIN HYDROCHLORIDE | Baxter Healthcare Corporation | 2024-01-25 |
| 00338-3551-48 | 100 mL in 1 BAG (0338-3551-48) | VANCOMYCIN HYDROCHLORIDE | Baxter Healthcare Corporation | 1958-11-14 |
| 00338-3552-48 | 200 mL in 1 BAG (0338-3552-48) | VANCOMYCIN HYDROCHLORIDE | Baxter Healthcare Corporation | 1958-11-14 |
| 00338-3580-48 | 200 mL in 1 BAG (0338-3580-48) | VANCOMYCIN HYDROCHLORIDE | Baxter Healthcare Corporation | 1958-11-14 |
| 00338-3581-01 | 100 mL in 1 BAG (0338-3581-01) | VANCOMYCIN HYDROCHLORIDE | Baxter Healthcare Corporation | 2015-12-18 |
| 00338-3582-01 | 150 mL in 1 BAG (0338-3582-01) | VANCOMYCIN HYDROCHLORIDE | Baxter Healthcare Corporation | 2015-12-18 |
| 00338-3583-01 | 200 mL in 1 BAG (0338-3583-01) | VANCOMYCIN HYDROCHLORIDE | Baxter Healthcare Corporation | 2015-12-18 |
| 70594-0041-02 | 6 BAG in 1 CARTON (70594-041-02) / 100 mL in 1 BAG (70594-0... | Vancomycin | Xellia Pharmaceuticals USA LLC | 2019-02-15 |
| 70594-0041-03 | 12 BAG in 1 CARTON (70594-041-03) / 100 mL in 1 BAG (70594-... | Vancomycin | Xellia Pharmaceuticals USA LLC | 2019-02-15 |
| 70594-0042-02 | 6 BAG in 1 CARTON (70594-042-02) / 200 mL in 1 BAG (70594-0... | Vancomycin | Xellia Pharmaceuticals USA LLC | 2019-02-15 |
| 70594-0042-03 | 12 BAG in 1 CARTON (70594-042-03) / 200 mL in 1 BAG (70594-... | Vancomycin | Xellia Pharmaceuticals USA LLC | 2019-02-15 |
| 70594-0043-02 | 6 BAG in 1 CARTON (70594-043-02) / 300 mL in 1 BAG (70594-0... | Vancomycin | Xellia Pharmaceuticals USA LLC | 2019-02-15 |
| 70594-0044-02 | 6 BAG in 1 CARTON (70594-044-02) / 400 mL in 1 BAG (70594-0... | Vancomycin | Xellia Pharmaceuticals USA LLC | 2019-02-15 |
| 70594-0056-02 | 6 BAG in 1 CARTON (70594-056-02) / 150 mL in 1 BAG (70594-0... | Vancomycin | Xellia Pharmaceuticals USA LLC | 2020-05-13 |
| 70594-0056-03 | 12 BAG in 1 CARTON (70594-056-03) / 150 mL in 1 BAG (70594-... | Vancomycin | Xellia Pharmaceuticals USA LLC | 2020-05-13 |
| 70594-0057-02 | 6 BAG in 1 CARTON (70594-057-02) / 250 mL in 1 BAG (70594-0... | Vancomycin | Xellia Pharmaceuticals USA LLC | 2020-05-13 |
| 70594-0058-02 | 6 BAG in 1 CARTON (70594-058-02) / 350 mL in 1 BAG (70594-0... | Vancomycin | Xellia Pharmaceuticals USA LLC | 2020-05-13 |
Observed labelers:
Hikma Pharmaceuticals USA Inc. (10) ·
Xellia Pharmaceuticals USA LLC (10) ·
Baxter Healthcare Corporation (8)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J3375 | Inj vancomycin (xellia) 10mg | 14 | CMS |
| J3373 | Inj, vancomycin hcl, 10 mg | 8 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.